Skip to main content

Skin and Structure Infection News (Page 2)

Related terms: Complicated Skin and Skin Structure Infection, cSSSI

FDA Approves Dalvance (dalbavancin) to Treat Skin Infections

May 23, 2014 – The U.S. Food and Drug Administration today approved Dalvance (dalbavancin), a new antibacterial drug used to treat adults with skin infections. Dalvance is intended to treat acute...

FDA Approves Teflaro for Bacterial Infections

SILVER SPRING, Md., Oct. 29 /PRNewswire-USNewswire/ – The U.S. Food and Drug Administration today approved Teflaro (ceftaroline fosamil), an injectable antibiotic to treat adults with community...

Theravance and Astellas Announce FDA Approval of Vibativ (telavancin) for the Treatment of Complicated Skin and Skin Structure Infections

SOUTH SAN FRANCISCO, CA and DEERFIELD, IL - September 11, 2009 - Theravance, Inc. and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Vibativ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Bacterial Infection

Related drug support groups

amoxicillin, metronidazole, doxycycline, cephalexin, clindamycin, azithromycin, Cipro, ciprofloxacin, Zithromax, view more... mupirocin, Augmentin, erythromycin, levofloxacin, Bactroban, clarithromycin, sulfamethoxazole / trimethoprim, vancomycin, cefdinir, amoxicillin / clavulanate